Vinorelbine is a type of chemotherapy drug used to treat certain kinds of cancer, like lung cancer and breast cancer. It works by stopping cancer cells from growing and dividing. It's given as an injection, usually into a vein.
Every report comes from a Lived member, sent anonymously.
Have you tried Vinorelbine for Non-Small Cell Lung Cancer?
Vinorelbine is a chemotherapy medicine given into a vein to treat cancer. In the US it is approved for non-small cell lung cancer (NSCLC), the most common type of lung cancer, when the cancer has grown into nearby tissue or spread to other parts of the body. It can be used alone or together with cisplatin, another chemotherapy drug. It was originally sold under the brand name Navelbine, which has since been discontinued in the US; it is now given as generic vinorelbine. Oncologists also use vinorelbine outside its approved label. With cisplatin, it is one of the chemotherapy combinations studied after surgery that has completely removed a lung cancer, where it improved long-term survival. It is also used for breast cancer that has spread, including in people who have already received other chemotherapy, and sometimes for other cancers such as soft tissue sarcomas. Whether it is the right choice depends on the cancer's type and stage, earlier treatments and overall health.
Vinorelbine belongs to a family of chemotherapy drugs called vinca alkaloids. When a cell divides, it builds a scaffold of tiny protein fibers called microtubules to pull its copied chromosomes apart. Vinorelbine binds to the building blocks of these fibers and stops the scaffold from forming, so the cell cannot complete division. Cancer cells divide often, so they are especially affected. Healthy cells that divide quickly, such as the bone marrow cells that make blood, are affected too, which explains the drug's main side effect on blood counts. Microtubules also help nerves carry signals, which is why vinorelbine can cause numbness and constipation.
Vinorelbine is given only into a vein, by a nurse in a clinic or hospital infusion center. Each dose runs in over about 6 to 10 minutes, followed by a flush of fluid to clear the vein. It is usually given once a week, either alone or on a schedule combined with cisplatin. The dose is calculated from body size. A blood count is checked before every dose. If white blood cells are too low, or liver tests show high bilirubin, the dose is reduced or that week's treatment is skipped. Many people have at least one dose reduction during treatment, and this is a routine part of keeping the drug safe rather than a sign that treatment is failing. If the drug leaks out of the vein into the surrounding skin, it can seriously damage the tissue. Tell the nurse right away about pain, burning, swelling, redness or blistering at the IV site, during the infusion or in the days after.
The most common effects are low blood counts, tiredness, nausea, vomiting, constipation, and pain or irritation along the vein used for the infusion. Some people notice mild hair thinning, diarrhea or numbness and tingling in the hands or feet. The most important risk, highlighted in a boxed warning (the FDA's strongest label warning), is a sharp drop in neutrophils, the white blood cells that fight bacteria. Counts are usually lowest 7 to 10 days after a dose. During this window an infection can become serious quickly, and some people have been hospitalized or died from sepsis. Call your cancer care team right away, at any hour, for a fever, chills, sore throat or other signs of infection. Vinorelbine can slow the bowel enough to cause severe constipation or a blockage. Care teams usually recommend a preventive plan of fiber, fluids and a stool softener from the start. Contact the team promptly for severe constipation, new belly pain, or nausea and vomiting that will not settle. Less often, the drug inflames the lungs, typically around a week after a dose; this can be life-threatening. Report new or worsening shortness of breath, cough or wheezing promptly. Also report numbness, tingling or weakness that is new or getting worse, because treatment is usually stopped if nerve damage reaches a moderate level.
Vinorelbine is broken down in the liver by an enzyme called CYP3A4. Medicines that strongly block this enzyme, such as the antifungals ketoconazole and itraconazole, the antibiotic clarithromycin and the HIV booster ritonavir, can raise vinorelbine levels and bring on side effects sooner or more severely. Grapefruit juice also blocks this enzyme. Give the care team a full list of prescriptions, over-the-counter medicines and supplements, and check before starting anything new. Because the liver clears the drug, liver problems also call for extra caution and regular liver blood tests. Vinorelbine can harm a developing baby. A pregnancy test is done before starting if pregnancy is possible. Women who could become pregnant should use effective birth control during treatment and for 6 months after the last dose, and men with partners who could become pregnant should do so for 3 months after the last dose. Breastfeeding should stop during treatment and for 9 days after the last dose. Vinorelbine may also affect male fertility, so it is worth asking about fertility options before treatment begins.
Treatment means weekly clinic visits for a blood test and a short infusion, often continuing for several months, depending on the plan and how the cancer responds. Most effects are felt in the week or two after each dose, with tiredness and the risk of infection peaking as blood counts reach their low point. Counts usually recover over the following one to two weeks, which is why the blood test before each weekly dose decides whether that dose goes ahead. The oncologist checks whether the cancer is responding with scans at set intervals. Treatment is adjusted to side effects along the way: doses are often lowered or delayed, and vinorelbine may be stopped if the cancer grows or side effects become too hard to manage. Having a clear plan for whom to call after hours, especially about fever, is an important part of being treated safely.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Vinorelbine, what you've noticed, or ask the community a question.